Hostname: page-component-78c5997874-v9fdk Total loading time: 0 Render date: 2024-11-08T05:20:37.583Z Has data issue: false hasContentIssue false
  • English
  • Français

Efficacy of oryzalin and associated histological changes in Cryptosporidium-infected neonatal rats

Published online by Cambridge University Press:  16 January 2003

A. ARMSON ,
K. MENON ,
A. O'HARA ,
L. M. MACDONALD ,
C. M. READ ,
K. SARGENT ,
R. C. A. THOMPSON  and
J. A. REYNOLDSON
A. ARMSON
Affiliation:
Centre for Biomolecular Control of Disease, Western Australian Biomedical Research Institute and Division of Veterinary and Biomedical Sciences, Murdoch University, Perth 6150, Australia
K. MENON
Affiliation:
Centre for Biomolecular Control of Disease, Western Australian Biomedical Research Institute and Division of Veterinary and Biomedical Sciences, Murdoch University, Perth 6150, Australia
A. O'HARA
Affiliation:
Centre for Biomolecular Control of Disease, Western Australian Biomedical Research Institute and Division of Veterinary and Biomedical Sciences, Murdoch University, Perth 6150, Australia
L. M. MACDONALD
Affiliation:
Centre for Biomolecular Control of Disease, Western Australian Biomedical Research Institute and Division of Veterinary and Biomedical Sciences, Murdoch University, Perth 6150, Australia
C. M. READ
Affiliation:
Centre for Biomolecular Control of Disease, Western Australian Biomedical Research Institute and Division of Veterinary and Biomedical Sciences, Murdoch University, Perth 6150, Australia
K. SARGENT
Affiliation:
Centre for Biomolecular Control of Disease, Western Australian Biomedical Research Institute and Division of Veterinary and Biomedical Sciences, Murdoch University, Perth 6150, Australia
R. C. A. THOMPSON
Affiliation:
Centre for Biomolecular Control of Disease, Western Australian Biomedical Research Institute and Division of Veterinary and Biomedical Sciences, Murdoch University, Perth 6150, Australia
J. A. REYNOLDSON
Affiliation:
Centre for Biomolecular Control of Disease, Western Australian Biomedical Research Institute and Division of Veterinary and Biomedical Sciences, Murdoch University, Perth 6150, Australia
Get access Rights & Permissions [Opens in a new window]

Abstract

This paper reports the anti-cryptosporidial effects of, and concomitant amelioration of the histological changes in the gut of neonatal rats with intestinal cryptosporidiosis treated with the dinitroaniline, oryzalin. The ED50 was determined to be 7 mg/kg using twice daily doses administered for 3 consecutive days. A maximum inhibition of 85.5% was achieved at 25 mg/kg and this inhibition remained constant despite increasing the oryzalin dose to 200 mg/kg. Cryptosporidiosis significantly decreased the intestinal villus/crypt (VC) ratio by approximately 50% (duodenum = 2.3, jejunum = 2.5 and ileum = 1.7) when compared to uninfected untreated controls (duodenum = 4.3, jejunum = 5.9 and ileum = 4.5). Treatment with oryzalin doubled the VC ratio in the duodenum, jejunum and ileum following doses of 5 mg, 50 mg and 200 mg/kg respectively. Oryzalin concentrations in the small intestine contents and plasma were determined, using HPLC, at 0.5, 1 and 2 h after dosing. The much greater dose required to return VC ratios to normal in the ileum (200 mg/kg) compared to the duodenum (6.25 mg/kg) appeared to reflect the decreased concentration of the drug in the distal small intestine. Concentrations of oryzalin equivalent to the in vitro IC50 were maintained for 2 h in the first half of the small intestine following a single dose of 100 mg/kg.

Keywords

Cryptosporidiumvillus/cryptdinitroanilineoryzalincoccidiosis
Type
Original Article
Information
Parasitology , Volume 125 , Issue 2 , August 2002 , pp. 113 - 117
Copyright
2002 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)